Back to LCTX
D1 Capital Partners L.P. → LCTX
D1 Capital Partners L.P. LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
8
Latest value
$204.8M
Q2 2026
Peak value
$259.1M
First seen
Q3 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2024 | $82.3M |
| Q4 2024 | $219.8M |
| Q1 2025 | $144.1M |
| Q2 2025 | $201.2M |
| Q3 2025 | $238.9M |
| Q4 2025 | $259.1M |
| Q1 2026 | $242.5M |
| Q2 2026 | $204.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $204.8M | 4.74M | — | — |
| Q1 2026 | $242.5M | 7.40M | — | — |
| Q4 2025 | $259.1M | 7.40M | — | — |
| Q3 2025 | $238.9M | 6.18M | — | — |
| Q2 2025 | $201.2M | 4.62M | — | — |
| Q1 2025 | $144.1M | 2.46M | — | — |
| Q4 2024 | $219.8M | 3.75M | — | — |
| Q3 2024 | $82.3M | 1.05M | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$200.2M
$151.1M
$151.1M
$150.8M